SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-19-000173
Filing Date
2019-03-01
Accepted
2019-03-01 16:00:47
Documents
2
Group Members
ORBIMED CAPITAL GP IV LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 ss127736_sc13da.htm SC 13D/A 122907
2 JOINT FILING AGREEMENT ss127736_ex9901.htm EX-1 30394
  Complete submission text file 0000947871-19-000173.txt   154883
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 1000 DE LA GAUCHETIERE STREET WEST SUITE 1200 MONTREAL A8 H3B 4W5
Business Address 1000 DE LA GAUCHETIERE STREET WEST SUITE 1200 MONTREAL A8 H3B 4W5 (514) 940-3600
Clementia Pharmaceuticals Inc. (Subject) CIK: 0001647320 (see all company filings)

IRS No.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90071 | Film No.: 19649137
SIC: 2834 Pharmaceutical Preparations